167 Results for "

PTK

" in MedChemExpress (MCE) Product Catalog:
Products (167)

167 Results for "PTK" in MCE Product Catalog:

  • Targets Recommended:
33
33 Publications Verification
Cat. No.: HY-14865
CAS No.: 389139-89-3
Purity:  99.85%
Synonyms: PTK 0796; Amadacycline
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796), a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
33
33 Publications Verification
Cat. No.: HY-14865B
CAS No.: 1075240-43-5
Purity:  99.37%
Synonyms: PTK 0796 tosylate; Amadacycline tosylate
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796) tosylate, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline tosylate acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline tosylate possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline tosylate can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
33
33 Publications Verification
Cat. No.: HY-14865C
CAS No.: 1196800-39-1
Purity:  99.47%
Synonyms: PTK0796 hydrochloride; Amadacycline hydrochloride
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Omadacycline (PTK 0796) hydrochloride, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline hydrochloride acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline hydrochloride possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline hydrochloride can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-10203
CAS No.: 212141-54-3
Purity:  99.93%
Synonyms: PTK787; ZK-222584; CGP-79787
Target:  

VEGFR

Research Areas:  

Cancer

Vatalanib (PTK787; ZK-222584; CGP-79787) is an inhibitor of VEGFR2/KDR with IC50 of 37 nM.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-12018
CAS No.: 212141-51-0
Purity:  99.68%
Synonyms: PTK787 dihydrochloride; ZK-222584 dihydrochloride; CGP-797870 dihydrochloride
Vatalanib dihydrochloride (PTK787 dihydrochloride) is a BBB-permeable VEGFR2/KDR inhibitor with an IC50 of 37 nM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-123919
CAS No.: 2229037-19-6
Purity:  98.15%
Research Areas:  

Cancer

TL13-112 is a potent and selective ALK-PROTAC degrader and inhibits ALK activity with an IC50 value of 0.14 nM. TL13-112 also prompts the degradation of additional kinases including Aurora A, FER, PTK2 and RPS6KA1 with IC50 values of 8550 nM, 42.4 nM, 25.4 nM, and 677 nM, respectively. TL13-112 is comprised of the conjugation of Ceritinib (HY-15656) and the Cereblon ligand of Pomalidomide (HY-10984) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111546
CAS No.: 2341740-84-7
Purity:  99.84%
Target:  

PROTACs FAK

Research Areas:  

Cancer

BI-3663 is a highly selective PTK2/FAK PROTAC (DC50 = 30 nM) with a Cereblon E3 ligase ligand capable of degrading PTK2, with an IC50 value of 18 nM. BI-3663 is a PROTAC generated by linking the PTK2/FAK inhibitor BI-4464 (HY-124625) with a Pomalidomide (HY-10984) derivative via a linker. BI-3663 can induce PTK2 degradation at low nanomolar concentrations. BI-3663 has antitumor activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P78619
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PTK7; CCK4; CCK-4; Tyrosine-protein kinase-like 7; Protein-tyrosine kinase 7; Protein-tyrosine kinase 7
Species:  
Rat
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P78761
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PTK7; CCK4; CCK-4; Tyrosine-protein kinase-like 7; Protein-tyrosine kinase 7; Protein-tyrosine kinase 7
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P99829
CAS No.: 1869937-48-3
Synonyms: PF-06647020; ABBV-647; h6M24-vc0101
Cofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb (hu6M024, IgG1) joined to an auristatin microtubule inhibitor payload, auristatin-0101 (Aur0101; HY-12522), by a cleavable valine-citrulline (vc)-based linker. Cofetuzumab pelidotin has a DAR of 4. Cofetuzumab pelidotin binds to cell-surface PTK7 with an EC50 of 1153 pM by flow cytometry. Cofetuzumab pelidotin has the potential for solid tumors research .
loading...
    loading...
Cat. No.: HY-P99828
CAS No.: 1869928-62-0
Synonyms: PF-06523435; hu24

Target:  

ADC Antibodies RET PERK ROR

Research Areas:  

Cancer

Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody targeting PTK7. The expression system of Cofetuzumab is typically CHO (Chinese hamster ovary) cells. Cofetuzumab downregulates PTK7 expression, modulates its downstream signaling pathways, and inhibits tumor sphere formation of ovarian cancer cells. Cofetuzumab can be used to synthesize the ADC molecule Cofetuzumab pelidotin (HY-P99829). Cofetuzumab is applicable to the research of tumors such as ovarian cancer .
loading...
    loading...
Cat. No.: HY-110244
CAS No.: 1600515-49-8
Purity:  99.69%
Target:  

BRK

Research Areas:  

Cancer

Tilfrinib (compound 4f) is a potent and selective Brk/PTK6 inhibitor with an IC50 value of 3.15 nM for Brk. Tilfrinib shows good anti-proliferative activity and has potential of anti-tumour .
loading...
    loading...
Cat. No.: HY-171830
CAS No.: 2408339-39-7
Synonyms: YX39-105
Research Areas:  

Cancer

MS105 (YX39-105) is an orally active and selective protein tyrosine kinase 6 (PTK6) (BRK) PROTAC degrader. MS105 recruits VHL E3 ligase via a VHL ligand moiety, promotes PTK6 ubiquitination and proteasomal degradation, inhibits the proliferation and migration of breast cancer cells, and induces apoptosis. MS105 shows potential for use in breast cancer research .
loading...
    loading...
Cat. No.: HY-124625
CAS No.: 1227948-02-8
Purity:  98.64%
BI-4464 is a highly selective, ATP competitive PTK2/FAK protein kinase inhibitor with an IC50 value of 17 nM. BI-4464 is a FAK (HY-43760) ligand and linker conjugate. BI-4464 can be used to construct proteolysis targeting chimeras (PROTACs), such as PROTAC FAK degrader 4 (HY-178467). PROTAC FAK degrader 4 is a highly potent and selective FAK PROTAC degrader .
loading...
    loading...
Cat. No.: HY-148065
CAS No.: 2769753-07-1
Purity:  98.77%
FMF-06-098-1 is a multi-target kinase PROTAC degrader. FMF-06-098-1 can be used to target degradation kinases which degrades AAK1, AΒL2, AURKA, AURKB, BUBIB, CDC7, CDK1, CDK12, CDK13, CDK2, CDK4, CDk6, CDK7, CDK9, CHEK1, CSNKID, EPHA1, PER, FGFR1, GAK, IRAK4, ITK, LIMK2, MAP4K2, MAP4K3, MAPK6, MAPK7, MARK4, MELK, PKN3, PLK4, PRKAA1, PTK2, PTK6, RPS6KA4, S1K2, STK35, TNK2, UHMK1, ULK1, and WEE1 .
loading...
    loading...
Cat. No.: HY-N2506
CAS No.: 83459-41-0
Ginsenoside Ra1 is a component from ginseng, inhibits protein tyrosine kinase (PTK) activation induced by hypoxia/reoxygenation .
loading...
    loading...
Cat. No.: HY-21291
CAS No.: 186611-55-2
Target:  

PDGFR EGFR IGF-1R

Research Areas:  

Cancer

SU-4313 is a potent protein tyrosine kinases (PTKs) modulator with IC50s of 14.5 μM, 18.8 μM, 11 μM, 16.9 μM, 8.0 μM for PDGFR, FLK-1, EGFR, HER2 Kinase and IGF-1R, respectively. SU-4313 has the potential for modulating tyrosine kinase signal transduction in order to regulate abnormal cell proliferation .
loading...
    loading...
Cat. No.: HY-14865S
CAS No.: 2272886-41-4
Purity:  99.21%
Synonyms: PTK 0796-d9; Amadacycline-d9
Omadacycline-d9 (PTK 0796-d9; Amadacycline-d9) is the deuterium labeled Omadacycline (HY-14865) that can be used as the internal standard for the analysis of Omadacycline .
loading...
    loading...
Cat. No.: HY-115514A
CAS No.: 2250025-98-8
Target:  

BRK

Research Areas:  

Cancer

BRK inhibitor P21d hydrochloride is a potent breast tumor kinase (BRK/PTK6) inhibitor with an IC50 of 30 nM. BRK inhibitor P21d hydrochloride inhibits p-SAM68 with an IC50 of 52 nM. BRK inhibitor P21d hydrochloride can be used to evaluate the in vivo activity of BRK inhibitors in xenograft breast tumor models .
loading...
    loading...
Cat. No.: HY-160488
CAS No.: 906147-24-8
Target:  

β-catenin

Research Areas:  

Cancer

PTK7/β-catenin-IN-1 (compound 01065) is a potent PTK7/β-catenin inhibitor with an IC50 of 8.9 μM and 56.5 μM for PTK7/β-catenin and p53/MDM2, respectively. PTK7/β-catenin-IN-1 has the potential for cancer research .
loading...
    loading...